Mercaptopurine in childhood acute lymphoblastic leukaemia (Q46390568)

21 December 2017

title

Mercaptopurine in childhood acute lymphoblastic leukaemia (English)

1 reference

21 December 2017

1 reference

1 reference

1

Paul S Gaynon

1 reference

21 December 2017

publication date

28 February 2017

1 reference

21 December 2017

Lancet Oncology Commission

published in

1 reference

21 December 2017

volume

18

1 reference

21 December 2017

issue

4

1 reference

21 December 2017

page(s)

425-426

1 reference

21 December 2017

Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930152-3

7 January 2021

Maintenance therapy of childhood acute lymphoblastic leukemia revisited-Should drug doses be adjusted by white blood cell, neutrophil, or lymphocyte counts?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930152-3

7 January 2021

Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930152-3

7 January 2021

Leucocyte versus erythrocyte thioguanine nucleotide concentrations in children taking thiopurines for acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930152-3

7 January 2021

DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930152-3

7 January 2021

Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930152-3

7 January 2021

Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group--protocol ALL-99.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930152-3

7 January 2021

Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930152-3

7 January 2021

10.1016/S1470-2045(17)30152-3

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

28258829

1 reference

21 December 2017